VYBRANÉ PUBLIKÁCIE
- Cholujova D, Bujnakova Z, Dutkova E, Hideshima T, Groen RW, Mitsiades CS, Richardson PG, Dorfman DM, Balaz P, Anderson KC, Jakubikova J. Realgar nanoparticles versus ATO arsenic compounds induce in vitro and in vivo activity against multiple myeloma. –2017-BR J HAEMATOL-Oct 19. doi: 10.1111/bjh.14974. PMID: 29048129
- Jakubikova J, Cholujova D, Hideshima T, Gronesova P, Soltysova A, Harada T, Joo J, Kong SY, Szalat RE, Richardson PG, Munshi NC, Dorfman DM, Anderson KC. A novel 3D mesenchymal stem cell model of the multiple myeloma bone marrow niche: biologic and clinical applications. –2016-ONCOTARGET- VOL7(47):77326-77341 PMID:27764795
- Pastorek M, Simko V, Takacova M, Barathova M, Bartosova M, Hunakova L, Sedlakova O, Hudecova S, Krizanova O, Dequiedt F, Pastorekova S, Sedlak J. Sulforaphane reduces molecular response to hypoxia in ovarian tumor cells independently of their resistance to chemotherapy.-2015- INT J ONCOL- VOL47 (1): 51-60. PMID: 25955133
https://www.spandidos-publications.com/ijo/47/1/51
- Zduriencikova M, Gronesova P, Cholujova D, Sedlak J: Potential biomarkers of exosomal cargo in endocrine signaling -2015-ENDOCR REGUL- VOL49(3):141-50. PMID: 26238497
https://www.ncbi.nlm.nih.gov/pubmed/26238497
- Hunakova L, Gronesova P, Horvathova E, Chalupa I, Cholujova D, Duraj J, Sedlak J. Modulation of cisplatin sensitivity in human ovarian carcinoma A2780 and SKOV3 cell lines by sulforaphane.-2014- TOXICOL LETT, VOL230 (3): 479-486. PMID: 25159039
http://www.sciencedirect.com/science/article/pii/S0378427414013083?via%3Dihub
- Cholujova D, Jakubikova J, Czako B, Martisova M, Hunakova L, Duraj J, Mistrik M, Sedlak J: MGN-3 arabinoxylan rice bran modulates innate immunity in multiple myeloma patients-2013-CANCER IMMUNOL IMMUNOTHER- VOL62(3):437-45. PMID: 22941038
https://link.springer.com/article/10.1007%2Fs00262-012-1344-z
- Jakubikova J, Adamia S, Kost-Alimova M, Klippel S, Cervi D, Daley JF, Cholujova D, Kong SY, Leiba M, Blotta S, Ooi M, Delmore J, Laubach J, Richardson PG, Sedlak J, Anderson KC, Mitsiades CS: Lenalidomide targets clonogenic side population in multiple myeloma: pathophysiologic and clinical implications-2011-BLOOD- VOL117(17):4409-19. PMID: 21321360
http://www.bloodjournal.org/content/117/17/4409.long?sso-checked=true
- Jakubikova J, Cervi D, Ooi M, Kim K, Nahar S, Klippel S, Cholujova D, Leiba M, Daley JF, Delmore J, Negri J, Blotta S, McMillin DW, Hideshima T, Richardson PG, Sedlak J, Anderson KC, Mitsiades CS: Anti-tumor activity and signaling events triggered by the isothiocyanates, sulforaphane and phenethyl isothiocyanate, in multiple myeloma-2011-HAEMATOLOGICA- VOL96(8):1170-9. PMID: 21712538